Lv1
80 积分 2025-12-01 加入
Safety and efficacy of rituximab in systemic sclerosis (DESIRES): a double-blind, investigator-initiated, randomised, placebo-controlled trial
2小时前
已完结
Real-world treatment for systemic sclerosis and systemic sclerosis-associated interstitial lung disease: information from a Japanese hospital claims database
3小时前
求助中
GPNMB immunohistochemistry is a useful ancillary tool for the diagnosis of pulmonary lymphangioleiomyomatosis
23天前
已完结
High-throughput Proteomics in Lymphangioleiomyomatosis: PMEL as a Diagnostic Biomarker, Construction of a Diagnosis Score and Evidence of Neutrophil Involvement
23天前
已关闭
Machine learning to distinguish lymphangioleiomyomatosis from other diffuse cystic lung diseases
25天前
已完结
High-throughput Proteomics in Lymphangioleiomyomatosis: PMEL as a Diagnostic Biomarker, Construction of a Diagnosis Score and Evidence of Neutrophil Involvement
25天前
已关闭
Nintedanib for patients with lymphangioleiomyomatosis: a phase 2, open-label, single-arm study
1个月前
已完结
Current Perspectives on The Diagnosis and Management of Lymphangioleiomyomatosis
1个月前
已关闭
Meningiomas in Lymphangioleiomyomatosis
1个月前
已完结
Perivascular Epithelioid Cell Neoplasms of Soft Tissue and Gynecologic Origin
1个月前
已完结
皖公网安备34019202002308
